Vitamin D3 Injectable from Talon Compounding Pharmacy Recalled for Sterility Assurance
Talon Compounding Pharmacy is recalling Vitamin D3 100,000 IU/mL injectable due to lack of assurance of sterility. The product was distributed across the United States, including Washington, D.C. and Puerto Rico.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: This is an FDA Class II recall for a compounded injectable drug with lack of sterility assurance. Per the rubric, FDA Class II recalls are typically scored as 2, but lack of sterility in injectable products represents a significant risk of infection and harm to patients, and the recall involves multiple lot numbers distributed nationwide, warranting a Severe (4) classification.
Plain-English summary
Vita Pharmacy, LLC dba Talon Compounding Pharmacy is recalling Vitamin D3 100,000 IU/mL Injectable (Rx only) due to lack of assurance of sterility. The recalled product was manufactured and distributed from Talon Compounding Pharmacy, located at 2950 Thousand Oaks Drive Suite 25, San Antonio, Texas 78247.
The affected product was distributed across the United States, including Washington, D.C. and Puerto Rico. A total of 23 vials were involved in this recall across multiple lot numbers with different beyond-use dates (BUDs).
Consumers and healthcare providers who have received this product should immediately discontinue use and contact Talon Compounding Pharmacy. Patients who have received injections of this product should consult with their healthcare provider regarding potential exposure to non-sterile compounded drugs.
The recalled product
- Product
- VITAMIN D3 100,000 IU/ML INJECTABLE 100,000IU/ML, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247
- Manufacturer
- Vita Pharmacy, LLC dba Talon Compounding Pharmacy
- Hazard
- sterility-assurance
- injection-safety
- contamination-risk
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (5)
- Lot: 05272021:20 BUD: 11/23/2021
- 06142021:34 BUD: 12/11/2021
- 08052021:18 BUD: 01/05/2022
- 08192021:43 BUD: 01/05/2022
- 03302021:15 BUD: 08/12/2021
Distribution
Distribution scope not specified by the agency.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27